A new phase of strategic investment
Alexis Jubert, President of Seiven, announces the acquisition of a 40% majority stake in the company, after buying out the shares of its initial investors. This move marks a strong desire to stabilize the group’s governance and embark on a new stage of expansion. Seiven, which also owns Isofroid, has eight brands covering the entire post-mortem process.
Objectif Europe: focus on external growth
Seiven aims to become a European reference by structuring its development around targeted acquisitions. Germany, Belgium, the Netherlands and the United Kingdom have been identified as high-potential markets. The challenge is to pool industrial expertise while preserving the local roots needed to support families.
